T22‐GFP‐H6‐FdU‐induced depletion of CXCR4‐overexpressing cancer cells in tumor tissue leading to reduced spheroid formation capacity T22‐GFP‐H6‐FdU‐induced.

Slides:



Advertisements
Similar presentations
Date of download: 7/9/2016 Copyright © 2016 SPIE. All rights reserved. Expression of the two luciferase variants in C17.2 cells. (a) Diagram of lentiviral.
Advertisements

Glioma-derived soluble factor(s) enhance IL-10 signaling.
Expression of follicular cell‐derived VEGF‐A and endothelial VEGFR is altered by different circulating TSH level Expression of follicular cell‐derived.
Effects of inhibiting inflammatory cell recruitment on fracture healing Treatment with CCR2 antagonist, INCB3344, led to impaired fracture healing compared.
Loss of Hdac3 impairs Ar signaling in mouse prostate tissues and has no effect on apoptosis Loss of Hdac3 impairs Ar signaling in mouse prostate tissues.
Trx80 is generated by α‐secretases. A
Impact of IRE1 somatic mutations on tumor development
The gene encoding TP53INP1 is expressed in pancreatic endocrine cells A, B(A, B) Immunocytofluorescent staining of TP53INP1 (red) and insulin (green) in.
[68Ga]Pentixafor PET imaging of MM xenografts Real‐time PCR analysis of cxcr4 transcript expression levels in HeLa (negative control) and in MM cell lines.
AAV8‐hAAT‐FGF21 treatment improves liver fibrosis
BRD4 is associated with poor patient survival and constitutes a promising target for NRASMut melanoma BRD4 is associated with poor patient survival and.
Dual LGR5 and KI67 knock‐in PDOs enable separation of quiescent and cycling LGR5+ CRC cells Dual LGR5 and KI67 knock‐in PDOs enable separation of quiescent.
Metabolic profile of Tfe3 KO mice
Both haematopoietic and non‐haematopoietic compartments are involved in myocarditis development.A.Kaplan‐Meier survival curves showing survival of bone.
Expression of FUT9 supports tumor development
ADAM8 promotes cancer cell adhesion to endothelial cells via β1‐integrin activation ABlood was drawn using the submandibular collection method from 4 mice/group.
TFE3 prevents diet‐induced obesity and metabolic syndrome
Selective biodistribution and receptor‐dependent uptake of T22‐GFP‐H6‐FdU in CXCR4+ cells in vivo Selective biodistribution and receptor‐dependent uptake.
JNK signaling mediates mammary tumor growth and metastasis to lungs
Negligible T22‐GFP‐H6‐FdU biodistribution or toxicity on non‐tumor tissues Negligible T22‐GFP‐H6‐FdU biodistribution or toxicity on non‐tumor tissues AUndetectable.
SPP1 and TNC promote chemoresistance
Inhibition of JNK signaling in breast cancer cells and lung colonization in a xenograft mouse model Inhibition of JNK signaling in breast cancer cells.
Superior potency of EnAd expressing EpCAM BiTE in partially EnAd‐resistant cancer cell line Superior potency of EnAd expressing EpCAM BiTE in partially.
Effect of VEGFA on ALDH+ population maintenance
NRP2 induces expression of GLI1. A,B
T22‐GFP‐H6‐FdU prevents metastasis in the M5 patient‐derived model in a CXCR4‐dependent manner T22‐GFP‐H6‐FdU prevents metastasis in the M5 patient‐derived.
Combination of OTX‐015 and PD does not induce overt toxicity
T22‐GFP‐H6‐FdU‐induced reduction in tumor re‐initiation capacity and blockade of tumor emboli intravasation in the CXCR4+ patient‐derived M5 model T22‐GFP‐H6‐FdU‐induced.
BETi potentiate the efficacy of MEKi in NRAS‐mutant melanoma
Inhibition of JNK signaling sensitizes mammary tumors and metastases to chemotherapy Inhibition of JNK signaling sensitizes mammary tumors and metastases.
Nec‐1 inhibits the phosphorylation and aggregation of tau
Lysozyme expression in isolated Paneth cells and linage tracing of Notch1+ cells Lysozyme expression in isolated Paneth cells and linage tracing of Notch1+
Hdac3 deletion decreases AKT phosphorylation and tumor growth in Pten knockout prostate cancer Hdac3 deletion decreases AKT phosphorylation and tumor growth.
The psoriatic phenotype of DKO
Impaired ECM protein synthesis in infarcted area of S100a4cre+/− × Fstl1flox/flox mice Impaired ECM protein synthesis in infarcted area of S100a4cre+/−
Effects of in vivo Nutlin‐3 treatment on CSC content of Numb− and Numb+ tumors Effects of in vivo Nutlin‐3 treatment on CSC content of Numb− and Numb+
SPP1 and TNC are induced by chemotherapy via JNK signaling
IL‐23‐induced psoriasis‐like skin disease is ameliorated in IL‐23−/− mice IL‐23‐induced psoriasis‐like skin disease is ameliorated in IL‐23−/− mice ARepresentative.
Assessment of intracerebral micro‐hemorrhages in APP23‐transgenic mice, dosed orally with CNP520 at 30 mg/kg for 3 months Assessment of intracerebral micro‐hemorrhages.
Hccs downregulation induces apoptosome‐independent caspase‐9 activation in mitochondria.A–C.TUNEL assays on st30 embryos co‐injected with hccs‐MO and Apaf1‐MO.
Cochlear explant and slice preparation, and CDDP‐induced DNA damage and cell death in sensory hair cells and spiral ganglion neurons Cochlear explant and.
EnAd‐EpCAMBiTE shows reproducible activity within an expanded cohort of patient malignant peritoneal and pleural exudates EnAd‐EpCAMBiTE shows reproducible.
In vivo efficacy of Olaparib in PTEN deficient xenografts.
BRD4 is associated with poor patient survival and constitutes a promising target for NRASMut melanoma BRD4 is associated with poor patient survival and.
Target engagement of the systemic Stat3 inhibitor in APP/PS1 mice
Scheme of FGF‐dependent regulation of TGFβ signaling in smooth muscle cells and endothelial cells Scheme of FGF‐dependent regulation of TGFβ signaling.
Features of the LIMT gene and RNA abundance in cell lines of different tissues of origin Features of the LIMT gene and RNA abundance in cell lines of different.
Derivation and application of cancer‐specific epithelial‐mesenchymal transition (EMT) signature A six‐step scheme illustrating the generation of a cancer‐specific.
Treatment with AZD5363 reduces the proportion of proliferating vascular endothelial cells and following RT, the influx of CD11b+ bone marrow‐derived cells.
Potentiation of P2X4R favors remyelination and ameliorates EAE
T22‐GFP‐H6‐FdU‐induced depletion of CXCR4‐overexpressing cancer cells in tumor tissue T22‐GFP‐H6‐FdU‐induced depletion of CXCR4‐overexpressing cancer cells.
Therapeutic activity of gal‐encapsulated cytotoxic drugs on tumor xenografts Therapeutic activity of gal‐encapsulated cytotoxic drugs on tumor xenografts.
Effect of D‐Asp treatment on myelination and remyelination in cerebellar organotypic slices Effect of D‐Asp treatment on myelination and remyelination.
P2X4R blockade increases pro‐inflammatory gene expression after EAE
Nilotinib inhibits DDR1 invasive activity of patient‐derived CRC cells
FGFR1 and TGFβ signaling activity in smooth muscle cells in a mouse atherosclerosis model FGFR1 and TGFβ signaling activity in smooth muscle cells in a.
Single‐molecule dynamics of the active mutant, hDIA1(R1204X), in XTC cells Single‐molecule dynamics of the active mutant, hDIA1(R1204X), in XTC cells A–DGFP‐tagged.
CNP520 treatment of male C57/BL6 mice for 8 weeks did not cause hair depigmentation CNP520 treatment of male C57/BL6 mice for 8 weeks did not cause hair.
Tangle formation and downregulation of miR‐132‐3p in LOAD A‐G
ADAM8 is induced by hypoxia and promotes angiogenesis ASixteen h after plating, cells were cultured under normoxic (−) or hypoxic (+, 1% O2) conditions.
UCN‐01 inhibits human IPF lung fibroblast pathological phenotypes and attenuates lung fibrosis induced by bleomycin injury UCN‐01 inhibits human IPF lung.
Bazedoxifene suppresses IL11‐mediated STAT3 signaling activity in human cancer cell lines and patient‐derived colon cancer primary cultures and organoids.
SEMA3C regulates prostate cancer cell growth
Niacin suppresses pro‐inflammatory cytokine expression in macrophages in DSS‐induced colitis in mice Niacin suppresses pro‐inflammatory cytokine expression.
ONC201 activates the ISR. ONC201 activates the ISR. (A) Western blotting analysis for ATF4, CHOP, ATF3, and TRB3 on lysates from HCT116 cells cultured.
Paclitaxel treatment along with CXCR2 knockdown reduces tumor growth and metastasis. Paclitaxel treatment along with CXCR2 knockdown reduces tumor growth.
Comparison of in vivo activity of 4D5scFvZZ and 4D5scFv.
Increased accumulation of pmel-1 T cells to tumor sites and enhanced antitumor immune response in mice receiving ACT combined with anti-PD-1 antibody treatment.
GCS-100 selectively kills KRAS-addicted lung tumors.
Fig. 3 Minimal treatment of ETL decreases metastatic burden and prolongs survival in the 4T1 breast carcinoma model after tumor resection. Minimal treatment.
Presentation transcript:

T22‐GFP‐H6‐FdU‐induced depletion of CXCR4‐overexpressing cancer cells in tumor tissue leading to reduced spheroid formation capacity T22‐GFP‐H6‐FdU‐induced depletion of CXCR4‐overexpressing cancer cells in tumor tissue leading to reduced spheroid formation capacity A, BT22‐GFP‐H6‐FdU depletes CXCR4+ cancer cells from SW1417 CRC tumor tissue after a 100 μg single‐dose administration. Note the reduction in CXCR4+ cell fraction in the tumor 24 h after injection, their almost complete elimination at 48 h, and the re‐emergence of CXCR4+ cells 72 h post‐administration, using anti‐CXCR4 IHC. In contrast, the CXCR4+ cancer cell fraction (CXCR4+ CCF) in tumor tissue remains constant along time after free oligo‐FdU treatment. The 3‐day time‐lapse for CXCR4+ tumor cell re‐appearance defines the dosage interval used in a repeated dose schedule of nanoconjugate administration in the experiments to evaluate its antimetastatic effect (N = 5: 5 mice/group; 1 samples/mouse). Scale bar, 50 μm. Data expressed as mean ± s.e.m. CXCR4 H‐score comparison for T22‐GFP‐H6‐FdU(T‐F)‐treated tumors among time points (green line, panel A). P‐values for statistical differences: T‐F Basal vs. T‐F 24 h, *P = 0.038; T‐F Basal vs. T‐F 48 h, **P = 0.001; T‐F Basal vs. T‐F 72 h, **P = 0.003; T‐F 24 h vs. T‐F 48 h, *P = 0.033. CXCR4 H‐score comparison between T22‐GFP‐H6‐FdU (T‐F) and free oligo‐FdU (F) (black line, panel A). P‐values for statistical differences: T‐F vs. F at 48 h, **P = 0.001; T‐F vs. F at 72 h, *P = 0.034). Mann–Whitney U‐test.C, DSignificant reduction in the number of spheroid formed (C, optical microscope) and their bioluminescence emission (D, IVIS Spectrum 200), generated by 1 × 106 disaggregated cells (cultured in stem cell‐conditioned media and low‐adhesion plates), obtained from CXCR4+ luciferase+ SW1417 subcutaneous tumors, 24 h after 100 μg T22‐GFP‐H6‐FdU intravenous doses, for 2 consecutive days, as compared to Buffer‐treated or free oligo‐FdU‐treated mice. (D) Quantitation of the bioluminescent signal (BLI) expressed as average radiant intensity, obtained using the IVIS spectrum 200 equipment (N = 2 plates/group). Data expressed as mean ± s.e.m. Comparison of emitted BLI between groups: (B: Buffer; F: free oligo‐FdU; T‐F: T22‐GFP‐H6‐FdU). P‐values for statistical differences: T‐F vs. B, **P = 0.001 (green line, panel D); F vs. B, *P = 0.011 (red line); T‐F vs. F at *P = 0.02 (black line, panel D). Mann–Whitney U‐test. María Virtudes Céspedes et al. EMBO Mol Med. 2018;emmm.201708772 © as stated in the article, figure or figure legend